Zobrazeno 1 - 10
of 115
pro vyhledávání: '"G Temperley"'
Autor:
E. Cazap, E. Triguboff, S. Breier, G. Uranga, M. R. Di Notto, L. Balbiani, A. Suarez, M. Trigo, G. Temperley, M.E. Pascual, F. Coppola, E. Mickiewicz, M. Rondinon, R. Estevez, S. Grasso, A. M. Bertoncin, D. Lewi, A. M. Alvarez, M. Ventriglia, C. Pazos, S. Jovtis
Publikováno v:
Breast Cancer Research and Treatment. 55:91-96
Purpose. To assess the response rate, survival, and toxicity of Taxol®(paclitaxel) as 1‐h infusion plus doxorubicin as first‐line treatment for patients with metastatic breast cancer (MBC). Patients and methods. Seventy‐six patients with untre
Autor:
L, Ezcurdia, S L, Jovtis, E, Mickiewicz, G, Temperley, M, Rondinón, C, Blajman, F S, Cóppola, D, Lewi, E, Cazap, S, Breier, H, Fasce, L, Fein, J, Polera, E, Triguboff, G, Uranga, G, Pasccón, A M, Luchina, C A, Martínez, P M, Politi, G, Rubio, A M, Alvarez
Publikováno v:
Seminars in oncology. 24(5 Suppl 15)
Paclitaxel (Taxol; Bristol-Myers Squibb Company; Princeton, NJ) is an antineoplastic agent that inhibits microtubular function and has shown efficacy in several solid tumors, mainly ovarian tumors, in which 20% to 40% response rates in previously tre
Autor:
N, Brocato, M F, Bruno, C E, Araujo, J C, Cervellino, C, Pirisi, G, Temperley, C, Sparrow, C, Savulsky, L R, Balbiani
Publikováno v:
Oncology. 52(1)
203 patients with inoperable non-small cell lung cancer (NSCLC) were randomized to receive ifosfamide (IFO) 2.5 g/m2 days 1-2 + epirubicin (EPI) 70 mg/m2 day 1 with cisplatin (DDP) 70 mg/m2 day 1 (arm IEP), or without cisplatin (arm IE). For uroproph
Publikováno v:
Lung Cancer. 29:84
Autor:
S. Jovtis, J Martinez, E. Almira, M Rondinon, M Orlando, D Maldonado, N Brocato, L Balbiani, M Bruno, G Cavarra, A.Z Comba, G Temperley
Publikováno v:
Lung Cancer. 29:46
Autor:
E. Mickiewicz, D. Lewi, M. Trigo, R. Estevez, S. Jovtis, M. Ventnglia, M. Di Noto, S. Grasso, A. M. Bertoncin, S. Breier, G. Rubio, M. Rondinon, A. M. Alvarez, G. Temperley, M.E. Pascual, G. Uranga, C. Bas, E. Cazap
Publikováno v:
European Journal of Cancer. 33:S152
Publikováno v:
European Journal of Cancer. 29:S162
Autor:
Pavlov, G. A.1 (AUTHOR) pavl4411@yandex.ru
Publikováno v:
Technical Physics. 2023 Suppl 2, Vol. 68, pS288-S294. 7p.
Autor:
C Savulsky, N Brocato, J. Cervellino, G Temperley, C.E Araujo, C Pirisi, L Balbiani, C Sparrow, M Bruno
Publikováno v:
Lung Cancer. 7:109
Publikováno v:
RSC Medicinal Chemistry; Oct2024, Vol. 15 Issue 10, p3286-3344, 59p